An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia
Mathew Cherian(The Ohio State University), Daniel A. Rauch(Washington University in St. Louis)
Cited by 27
Related Papers
Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade
|Blood|2019|106
Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
|Frontiers in Oncology|2022|20
Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma
|Retrovirology|2020|16
Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma
|Nanomaterials|2021|12
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer
|Breast Cancer Research|2024|7